Search BRITE hierarchies

Therapeutic category of drugs in Japan [BR:br08301]
  3  Agents affecting metabolism
    39  Other agents affecting metabolism
      396  Antidiabetic agents
        3969  Others
          D09978  Tofogliflozin (USAN); Tofogliflozin hydrate (JAN)

Drug groups [BR:br08330]
  Antidiabetic agent
    DG02044  Hypoglycemic agent
      DG01794  SGLT2 inhibitor
        D09978  Tofogliflozin
  Metabolizing enzyme substrate
    DG02977  CYP2C18 substrate
      D09978  Tofogliflozin
    DG02978  CYP4A11 substrate
      D09978  Tofogliflozin
    DG02979  CYP4F3 substrate
      D09978  Tofogliflozin

Drug classes [BR:br08332]
  Antidiabetic agent
    DG01794  SGLT2 inhibitor
      D09978  Tofogliflozin
    DG02044  Hypoglycemic agent
      D09978  Tofogliflozin

Target-based classification of drugs [BR:br08310]
  Transporters
    Solute carrier family
      SLC5
        SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]
          D09978  Tofogliflozin (USAN) <JP>

New drug approvals in Japan [br08318.html]
  D09978

New drug approvals in the USA, Europe and Japan [br08328.html]
  D09978

Drug metabolizing enzymes and transporters [br08309.html]
  D09978